GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Down 24.6% in February

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a significant drop in short interest in the month of February. As of February 27th, there was short interest totaling 28,292 shares, a drop of 24.6% from the February 12th total of 37,508 shares. Based on an average daily volume of 37,296 shares, the days-to-cover ratio is presently 0.8 days. Approximately 2.9% of the shares of the stock are short sold. Approximately 2.9% of the shares of the stock are short sold. Based on an average daily volume of 37,296 shares, the days-to-cover ratio is presently 0.8 days.

Institutional Investors Weigh In On GlucoTrack

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE grew its holdings in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after buying an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC purchased a new position in shares of GlucoTrack in the fourth quarter worth about $52,000. Finally, Ikarian Capital LLC acquired a new position in GlucoTrack during the fourth quarter worth about $177,000. Institutional investors and hedge funds own 10.92% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of GlucoTrack in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

GlucoTrack Price Performance

Shares of NASDAQ:GCTK traded down $0.06 during trading on Friday, reaching $1.21. The stock had a trading volume of 77,806 shares, compared to its average volume of 40,606. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.53 and a current ratio of 1.53. GlucoTrack has a 1-year low of $1.11 and a 1-year high of $30.51. The stock has a market cap of $1.22 million, a PE ratio of -0.03 and a beta of 0.33. The business has a fifty day moving average price of $2.38 and a 200-day moving average price of $4.64.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.